Absolute contraindications to GLP-1 receptor agonists include: Personal history of medullary thyroid carcinoma Family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Pregnancy (for weight management indications) Severe gastrointestinal disease, including gastroparesis Patients should be specifically questioned about these conditions during pre-treatment evaluation
Modern players expect platforms that pair excitement with responsibility, blending smart design, crisp navigation, and clear information about bonuses and wagering
Consequences of dehydration on GLP-1s : Worsened nausea and constipation Fatigue and headaches Kidney stress Reduced weight loss (dehydration mimics hunger) Target : 2-3 liters (64-96 oz) of water daily , more if exercising or in hot weather
Tirzepatide (Zepbound): SURMOUNT-5 trial Tirzepatide is a dual GLP-1/GIP receptor agonist that builds on single-hormone agents by targeting an additional pathway for enhanced satiety
Notably, weight loss had not plateaued at 52 weeks, suggesting potential for further reduction with continued treatment [44]